References
- Lopez-Montes A, Gallego E, Lopez E, et al. Treatment of tuberculosis with rifabutin in a renal transplant recipient. Am J Kidney Dis 2004;44:e59-e63. https://doi.org/10.1016/S0272-6386(04)00947-3
- Hickey MD, Quan DJ, Chin-Hong PV, Roberts JP. Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation. Liver Transpl 2013;19:457-461. https://doi.org/10.1002/lt.23622
- Apseloff G. Severe neutropenia among healthy volunteers given rifabutin in clinical trials. Clin Pharmacol Ther 2003;74:591-592. https://doi.org/10.1016/j.clpt.2003.08.008
- Chitre MM, Berenson CS. Idiosyncratic rifabutin-induced leukopenia and SIADH: case report and review. Pharmacotherapy 2001;21:493-497. https://doi.org/10.1592/phco.21.5.493.34488
- Hafner R, Bethel J, Standiford HC, et al. Tolerance and pharmacokinetic interactions of rifabutin and azithromycin. Antimicrob Agents Chemother 2001;45:1572-1577. https://doi.org/10.1128/AAC.45.5.1572-1577.2001
Cited by
- Rifabutin : Recurrent neutropenia: case report vol.1515, pp.1, 2014, https://doi.org/10.1007/s40278-014-2853-7
- Rifabutin for treating tuberculosis in solid organ transplant recipients: A retrospective observational study and literature review vol.23, pp.2, 2014, https://doi.org/10.1111/tid.13471